Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2013 Apr 5;121(9):340–346. [Article in Spanish] doi: 10.1016/S0025-7753(03)73942-6

Síndrome respiratorio agudo grave: ¿final o paréntesis de una epidemia?

Àngela Domínguez a,*, Francesc Gudiol b, Tomás Pumarola c, Lluís Salleras a
PMCID: PMC7130471  PMID: 14499072

The content is available as a PDF (150.2 KB).

Referencias Bibliográficas

  • 1.Salleras L. Síndrome respiratorio agudo grave. Una nueva enfermedad infecciosa. Med Clin (Barc) 2003;120:619–621. doi: 10.1016/S0025-7753(03)73789-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Pumarola T., Domínguez A. Síndrome respiratorio agudo grave. Med Clin (Barc) 2003;120:626–629. doi: 10.1016/S0025-7753(03)73791-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Peiris J.S.M., Lai S.T., Poon L.L.M., Guan Y., Yam L.Y.C., Lim W. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003;361:1319–1325. doi: 10.1016/S0140-6736(03)13077-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Ksiazek T.G., Erdman D., Goldsmith C., Zaki S.R., Peret T., Emery S. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003;348:1953–1966. doi: 10.1056/NEJMoa030781. [DOI] [PubMed] [Google Scholar]
  • 5.Drosten C., Günther S., Preiser W., Van der Werf S., Brodt H.R., Becker S. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003;348:1967–1976. doi: 10.1056/NEJMoa030747. [DOI] [PubMed] [Google Scholar]
  • 6.Rota P.A., Oberste M.S., Monroe S.S., Nix W.A., Campagnoli R., Icenogle J.P. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science. 2003;300:1394–1399. doi: 10.1126/science.1085952. [DOI] [PubMed] [Google Scholar]
  • 7.Marra M.A., Jone S.J.M., Astell C.R., Holt R.A., Brooks-Wilson A., Butterfield Y.S.N. The genome sequence of the SARS-associated coronavirus. Science. 2003;300:1399–1404. doi: 10.1126/science.1085953. [DOI] [PubMed] [Google Scholar]
  • 8.Fouchier R.A.M., Kuiken T., Schutten M., Amerongen G., Doornum G.J.J., Hoogen B.G. Koch's postulates fullfilled for SARS virus. Nature. 2003;423:240. doi: 10.1038/423240a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Holmes K.V. Coronaviruses. In: Knipe D.M., Howley D.M., editors. Fields Virology, 4th ed. Lippincott Williams and Wilkins; Philadelphia: 2001. pp. 1187–1203. [Google Scholar]
  • 10.Linden M., Greiff L., Andersson M., Svensson C., Akerlund A., Bende M. Nasal cytokines in common cold and allergic rinitis. Clin Exp Allergy. 1995;25:166–172. doi: 10.1111/j.1365-2222.1995.tb01022.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Kuo L., Godeke G.J., Raamsman M.J., Masters P.S., Rottier P.J. Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier. J Virol. 2000;74:1393–1406. doi: 10.1128/jvi.74.3.1393-1406.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Sánchez C.M., Izeta A., Sánchez-Morgado J.M., Alonso S., Solá I., Balasch M. Targeted recombination demonstrates that the spike gene of transmissible gastroenteritis coronavirus is a determinant of its enteric tropism and virulence. J Virol. 1999;73:7607–7618. doi: 10.1128/jvi.73.9.7607-7618.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Phillips J.J., Chua M.M., Lavi E., Weiss S.R.J. Pathogenesis of chimeric MHV4/MHV-A59 recombinant viruses: the murine coronavirus spike protein is a major determinant of neurovirulence. J Virol. 1999;73:7752–7760. doi: 10.1128/jvi.73.9.7752-7760.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Bergmann C.C., Yao Q., Lin M., Stohlman S.A. The JHM strain of mouse hepatitis virus induces a spike protein-specific Db-restricted cytotoxic T cell response. J Gen Virol. 1996;77:315–325. doi: 10.1099/0022-1317-77-2-315. [DOI] [PubMed] [Google Scholar]
  • 15.Ruan Y.J., Wei C.L., Ee L.A., Vega V.B., Thoreau H., Yun S.T.S. Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet. 2003;361:1779–1785. doi: 10.1016/S0140-6736(03)13414-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.World Health Organization. First data on stability and resistance of SARS coronavirus compiled by members of WHO Laboratory network. Disponible en: http://www.who.int/csr/sars/survival_2003_05_04/en/index.html
  • 17.World Health Organization. Case definitions for surveillance of Severe Acute Respiratory Syndrome (SARS). Disponible en: http://www.who.int/csr/sars/casedefinition/en/print.html
  • 18.World Health Organization. Epidemic curves-Severe Acute Respiratory Syndrome (SARS). Disponible en: http://www.who.int/csr/sarsepicurve/epiindex/en/
  • 19.Maunder R., Hunter J., Vincent L., Bennett J., Peladeau N., Leszcz M. The immediate psychological and occupational impact of the 2003 SARS outbreak in a teaching hospital. Can Med Assoc J. 2003;168:1245–1251. [PMC free article] [PubMed] [Google Scholar]
  • 20.CDC Update: Severe acute respiratory syndrome-Toronto, Canada 2003. MMWR. 2003;55:547–550. [PubMed] [Google Scholar]
  • 21.Li T.S., Buckley T.A., Yap F.H., Sung J.J., Joynt G.M. Severe acute respiratory syndrome (SARS): infection control. Lancet. 2003;361:1386. doi: 10.1016/S0140-6736(03)13052-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Rainer T.H., Cameron P.D., Smith D.V., Ong K.L., Hung A.N.W., Nin D.C.P. Evaluation of WHO criteria for indentitying patients with severe acute respiratory syndrome out of hospital: prospective observational study. BMJ. 2003;326:1354–1358. doi: 10.1136/bmj.326.7403.1354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Donnelly C.A., Ghani A.C., Leung G.M., Hedley A.J., Fraser C., Riley S. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet. 2003;361:1761–1766. doi: 10.1016/S0140-6736(03)13410-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Booth C.M., Matukas L.M., Tomlinson G.A., Rachlis A.R., Rose D.B., Dwosh H.A. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003;289:2801–2809. doi: 10.1001/jama.289.21.JOC30885. [DOI] [PubMed] [Google Scholar]
  • 25.Lee N., Llui D., Wu A., Chan P., Cameron P., Joynt G.M. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348:1986–1994. doi: 10.1056/NEJMoa030685. [DOI] [PubMed] [Google Scholar]
  • 26.Peiris J.S.M., Lai S.T., Poon L.L.M., Guan Y., Yam L.Y.C., Lim W. Coronavirus as possible cause of severe acute respiratory syndrome. Lancet. 2003;361:1319–1325. doi: 10.1016/S0140-6736(03)13077-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Peiris J.S., Chu C.M., Cheng V.C., Chan K.S., Hung I.F., Poon L.L. por el HKU/UCH SARS Study Group. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361:1767–1772. doi: 10.1016/S0140-6736(03)13412-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Tsang K.W., Ho P.L., Ooi G.C., Yee W.K., Wang T., Chan-Yeung M. Cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348:1977–1985. doi: 10.1056/NEJMoa030666. [DOI] [PubMed] [Google Scholar]
  • 29.Hon K.L., Leung T.F., Cheng W.T.F., Chan P.K.S., Chu W.C.W., Kwan Y.W. Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet. 2003;361:1701–1703. doi: 10.1016/S0140-6736(03)13364-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Reilley B., Van Herp M., Sermand D., Dentico N. SARS and Carlo Urbani. N Engl J Med. 2003;348:1951–1952. doi: 10.1056/NEJMp030080. [DOI] [PubMed] [Google Scholar]
  • 31.World Health Organization. Severe Acute Respiratory Syndrome (SARS): laboratory diagnostic tests. Disponible en: http://www.who.int/csr/sars/ diagnostictests/en/print.html
  • 32.World Health Organization. Use of laboratory methods for SARS diagnosis. Disponible en: http://www.who.int/csr/sars/labmethods/en/print.html
  • 33.World Health Organization. Sampling for Severe Acute Respiratory Syndrome (SARS) diagnostic tests. Disponible en: http://www.who.int/csr/sars/sampling/en/print.html
  • 34.World Health Organization. WHO biosafety guidelines for handling of SARS specimens. Disponible en: http://www.who.int/csr/sars/biosafety 2003_04_25/en/print.html
  • 35.Cinati J., Morgenstern B., Bauer G., Chandra P., Rabenau H., Doerr H.W. Glycirrhizin, an active component of liquoruce roots, and replication of SARS-associated coronavirus. Lancet. 2003;361:2045–2046. doi: 10.1016/S0140-6736(03)13615-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Poutanen S.N., Low D.E., Henry B., Finkelstein S., Rose D., Green K. Identification of severe acute respiratory syndrome in Canada. N Engl J Med. 2003;348:1995–2005. doi: 10.1056/NEJMoa030634. [DOI] [PubMed] [Google Scholar]
  • 37.Drazen J.M. Case clusters of the severe acute respiratory syndrome. N Engl J Med. 2003;348:e6–e7. doi: 10.1056/NEJMe030062. [DOI] [PubMed] [Google Scholar]
  • 38.WHO SARS outbreak in the Philippines. Wkly Epidemiol Rec. 2003;78:189–196. [PubMed] [Google Scholar]
  • 39.CDC Update: Severe acute respiratory syndrome United States. MMWR. 2003;52:525–526. [PubMed] [Google Scholar]
  • 40.Seto W.H., Yung R.W.H., Ching T.Y., Ho T.K., Ho L.M., Peiris J.S.M. Effectiveness of precaution againts droplet and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS) Lancet. 2003;361:1519–1520. doi: 10.1016/S0140-6736(03)13168-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Treanor J.J. Influenza virus. In: Mandell J.E., Nennet J.E., Dolin R., editors. Principles and practice of infectious diseases. 5.a ed. Churchill Livingstone; Philadelphia: 2000. pp. 1823–1849. [Google Scholar]
  • 42.Chin J., editor. Control of communicable diseases manual. 17.a ed. American Public Health Association; Washington: 2000. [Google Scholar]
  • 43.Ladman B.S., Pope C.R., Ziegler A.F., Swieczkowski T., Callahan C.J., Davison S. Protection of chickens after live and inactivated virus vaccination against challenge with nephropathogenic infectious bronchitis at hatch. Avian Dis. 2002;46:938–944. doi: 10.1637/0005-2086(2002)046[0938:POCALA]2.0.CO;2. [DOI] [PubMed] [Google Scholar]
  • 44.Ignjatovic J., Galli L. The S1 glycoprotein but not the N or M proteins of avian infectious bronchitis virus induces protection in vaccinated chickens. Arch Virol. 1994;138:117–134. doi: 10.1007/BF01310043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Fehr D., Holznagel E., Bolla S., Hauser B., Herrewegh A.A., Horzinek M.C. Placebo-controlled evaluation of a modified life virus vaccine against feline infectious peritonitis: safety and efficacy under field conditions. Vaccine. 1997;15:1101–1109. doi: 10.1016/S0264-410X(97)00006-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Corapi W.V., Darteil R.J., Audonnet J.C., Chappuis G.E. Localization of antigenic sites of the S glycoprotein of feline infectious peritonitis virus involved in neutralization and antibody-dependent enhancement. J Virol. 1995;69:2858–2862. doi: 10.1128/jvi.69.5.2858-2862.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Olsen C.W. A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination [review] Vet Microbiol. 1993;36:1–37. doi: 10.1016/0378-1135(93)90126-R. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.World Health Organization. Update 64-Situation in Toronto, detection of SARS-line virus in wild animals. Disponible en: http://www.who.int/csr/don/2003_05_23b/en/print.html
  • 49.WHO. Update 84. Can SARS be eradicated or eliminated? Disponible en: http://www.who.int/csr/don/2003_06_19/en/print.html

Articles from Medicina Clinica are provided here courtesy of Elsevier

RESOURCES